HB 1089 -- Health Insurance

Sponsor:  Schaaf

This bill requires health insurers to cover routine patient care
costs incurred as a result of phase I and phase II clinical
trials for cancer treatment.  Currently, coverage is only
required for phase III and IV of these trials.

Missouri House of Representatives
93rd General Assembly, 2nd Regular Session
Last Updated November 29, 2006 at 9:42 am